Logo image of YAR.OL

YARA INTERNATIONAL ASA (YAR.OL) Stock Fundamental Analysis

OSL:YAR - Euronext Oslo - NO0010208051 - Common Stock - Currency: NOK

383.4  -0.7 (-0.18%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to YAR. YAR was compared to 68 industry peers in the Chemicals industry. YAR has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on YAR.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

YAR had positive earnings in the past year.
In the past year YAR had a positive cash flow from operations.
Each year in the past 5 years YAR has been profitable.
Each year in the past 5 years YAR had a positive operating cash flow.
YAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

The Return On Assets of YAR (4.15%) is better than 70.59% of its industry peers.
The Return On Equity of YAR (8.70%) is better than 64.71% of its industry peers.
With a decent Return On Invested Capital value of 7.66%, YAR is doing good in the industry, outperforming 75.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for YAR is above the industry average of 6.25%.
Industry RankSector Rank
ROA 4.15%
ROE 8.7%
ROIC 7.66%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
YAR.OL Yearly ROA, ROE, ROICYAR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

YAR has a Profit Margin of 4.80%. This is in the better half of the industry: YAR outperforms 66.18% of its industry peers.
YAR's Profit Margin has declined in the last couple of years.
YAR has a Operating Margin of 8.66%. This is in the better half of the industry: YAR outperforms 67.65% of its industry peers.
YAR's Operating Margin has declined in the last couple of years.
YAR has a Gross Margin of 27.45%. This is comparable to the rest of the industry: YAR outperforms 44.12% of its industry peers.
YAR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.66%
PM (TTM) 4.8%
GM 27.45%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
YAR.OL Yearly Profit, Operating, Gross MarginsYAR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so YAR is still creating some value.
YAR has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, YAR has less shares outstanding
The debt/assets ratio for YAR is higher compared to a year ago.
YAR.OL Yearly Shares OutstandingYAR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
YAR.OL Yearly Total Debt VS Total AssetsYAR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.60 indicates that YAR is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.60, YAR is doing good in the industry, outperforming 67.65% of the companies in the same industry.
The Debt to FCF ratio of YAR is 7.06, which is on the high side as it means it would take YAR, 7.06 years of fcf income to pay off all of its debts.
YAR's Debt to FCF ratio of 7.06 is fine compared to the rest of the industry. YAR outperforms 66.18% of its industry peers.
YAR has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
YAR has a Debt to Equity ratio (0.43) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 7.06
Altman-Z 2.6
ROIC/WACC0.91
WACC8.44%
YAR.OL Yearly LT Debt VS Equity VS FCFYAR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.60 indicates that YAR should not have too much problems paying its short term obligations.
YAR's Current ratio of 1.60 is in line compared to the rest of the industry. YAR outperforms 45.59% of its industry peers.
A Quick Ratio of 0.83 indicates that YAR may have some problems paying its short term obligations.
YAR has a worse Quick ratio (0.83) than 73.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 0.83
YAR.OL Yearly Current Assets VS Current LiabilitesYAR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

YAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.02%, which is quite impressive.
The earnings per share for YAR have been decreasing by -11.01% on average. This is quite bad
The Revenue has been growing slightly by 2.93% in the past year.
The Revenue has been growing slightly by 1.52% on average over the past years.
EPS 1Y (TTM)76.02%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%111.63%
Revenue 1Y (TTM)2.93%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%11.89%

3.2 Future

Based on estimates for the next years, YAR will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.73% on average per year.
YAR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.71% yearly.
EPS Next Y76.67%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
EPS Next 5Y-11.73%
Revenue Next Year8.55%
Revenue Next 2Y3.59%
Revenue Next 3Y2.8%
Revenue Next 5Y2.71%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
YAR.OL Yearly Revenue VS EstimatesYAR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
YAR.OL Yearly EPS VS EstimatesYAR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.30, YAR is valued correctly.
YAR's Price/Earnings ratio is rather cheap when compared to the industry. YAR is cheaper than 86.76% of the companies in the same industry.
YAR is valuated cheaply when we compare the Price/Earnings ratio to 26.82, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 11.66 indicates a reasonable valuation of YAR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of YAR indicates a somewhat cheap valuation: YAR is cheaper than 70.59% of the companies listed in the same industry.
YAR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.21.
Industry RankSector Rank
PE 12.3
Fwd PE 11.66
YAR.OL Price Earnings VS Forward Price EarningsYAR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, YAR is valued cheaper than 86.76% of the companies in the same industry.
76.47% of the companies in the same industry are more expensive than YAR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.95
EV/EBITDA 5.45
YAR.OL Per share dataYAR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
YAR has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as YAR's earnings are expected to grow with 17.28% in the coming years.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y35.44%
EPS Next 3Y17.28%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.30%, YAR has a reasonable but not impressive dividend return.
YAR's Dividend Yield is comparable with the industry average which is at 3.05.
With a Dividend Yield of 1.30, YAR pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

The dividend of YAR decreases each year by -8.80%.
Dividend Growth(5Y)-8.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

YAR pays out 17.97% of its income as dividend. This is a sustainable payout ratio.
YAR's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP17.97%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
YAR.OL Yearly Income VS Free CF VS DividendYAR.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
YAR.OL Dividend Payout.YAR.OL Dividend Payout, showing the Payout Ratio.YAR.OL Dividend Payout.PayoutRetained Earnings

YARA INTERNATIONAL ASA

OSL:YAR (8/1/2025, 7:00:00 PM)

383.4

-0.7 (-0.18%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-18 2025-07-18/bmo
Earnings (Next)10-17 2025-10-17/bmo
Inst Owners42.41%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap97.66B
Analysts65.19
Price Target381.7 (-0.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend4.88
Dividend Growth(5Y)-8.8%
DP17.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.06%
Min EPS beat(2)-7.59%
Max EPS beat(2)37.7%
EPS beat(4)2
Avg EPS beat(4)8.26%
Min EPS beat(4)-47.21%
Max EPS beat(4)50.14%
EPS beat(8)4
Avg EPS beat(8)58.19%
EPS beat(12)6
Avg EPS beat(12)23.58%
EPS beat(16)7
Avg EPS beat(16)11.87%
Revenue beat(2)2
Avg Revenue beat(2)0.26%
Min Revenue beat(2)0.19%
Max Revenue beat(2)0.33%
Revenue beat(4)2
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-3.34%
Max Revenue beat(4)0.33%
Revenue beat(8)2
Avg Revenue beat(8)-6.35%
Revenue beat(12)3
Avg Revenue beat(12)-4.87%
Revenue beat(16)4
Avg Revenue beat(16)-3.72%
PT rev (1m)3.47%
PT rev (3m)7.96%
EPS NQ rev (1m)20.92%
EPS NQ rev (3m)39.9%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)5.2%
Revenue NQ rev (3m)9.14%
Revenue NY rev (1m)2.09%
Revenue NY rev (3m)2.27%
Valuation
Industry RankSector Rank
PE 12.3
Fwd PE 11.66
P/S 0.65
P/FCF 15.95
P/OCF 5.85
P/B 1.17
P/tB 1.31
EV/EBITDA 5.45
EPS(TTM)31.18
EY8.13%
EPS(NY)32.87
Fwd EY8.57%
FCF(TTM)24.03
FCFY6.27%
OCF(TTM)65.59
OCFY17.11%
SpS593.46
BVpS327.67
TBVpS292.42
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.15%
ROE 8.7%
ROCE 10.03%
ROIC 7.66%
ROICexc 8.2%
ROICexgc 8.85%
OM 8.66%
PM (TTM) 4.8%
GM 27.45%
FCFM 4.05%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
ROICexc(3y)11.17%
ROICexc(5y)10.65%
ROICexgc(3y)12.02%
ROICexgc(5y)11.5%
ROCE(3y)13.48%
ROCE(5y)12.99%
ROICexcg growth 3Y-20.87%
ROICexcg growth 5Y0.34%
ROICexc growth 3Y-20.66%
ROICexc growth 5Y0.45%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
F-Score6
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 7.06
Debt/EBITDA 1.5
Cap/Depr 96.69%
Cap/Sales 7%
Interest Coverage 4.9
Cash Conversion 69.5%
Profit Quality 84.31%
Current Ratio 1.6
Quick Ratio 0.83
Altman-Z 2.6
F-Score6
WACC8.44%
ROIC/WACC0.91
Cap/Depr(3y)107.36%
Cap/Depr(5y)98.34%
Cap/Sales(3y)6.55%
Cap/Sales(5y)6.27%
Profit Quality(3y)1242.99%
Profit Quality(5y)807.54%
High Growth Momentum
Growth
EPS 1Y (TTM)76.02%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%111.63%
EPS Next Y76.67%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
EPS Next 5Y-11.73%
Revenue 1Y (TTM)2.93%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%11.89%
Revenue Next Year8.55%
Revenue Next 2Y3.59%
Revenue Next 3Y2.8%
Revenue Next 5Y2.71%
EBIT growth 1Y68.09%
EBIT growth 3Y-20.82%
EBIT growth 5Y-2.34%
EBIT Next Year149.37%
EBIT Next 3Y35.87%
EBIT Next 5Y12.96%
FCF growth 1Y-52.42%
FCF growth 3Y-28.42%
FCF growth 5Y-24.89%
OCF growth 1Y-29.75%
OCF growth 3Y-2.93%
OCF growth 5Y-7.58%